Exposure-Based CBT for Youth With Blood and Injection Phobia and Chronic Illness

Region Stockholm

Status: Not yet enrolling

Conditions: Blood Injury Phobia; Injection Fear

Treatments: Behavioral: Exposure based CBT

Study type: Interventional

Funder types: Other

Identifiers

NCT07125287

2024-08344-01

K 2025-5350 (Other Identifier)

Details and patient eligibility

About

More than half of all children fear needles, and hospitalized children often describe injections as the most frightening part of medical care. While mild needle fear can often be managed by healthcare staff using distraction and reassurance, these strategies are ineffective for children with blood-injection-injury phobia (BII phobia). Children with BII phobia and co-occurring chronic medical conditions often require repeated blood tests or injections, but their phobia may prevent essential treatment. In such cases, healthcare providers may be forced to use physical restraint, sedation, or general anesthesia-approaches that are distressing for the child and costly for the healthcare system.

Although exposure-based cognitive behavioral therapy (CBT) is an effective treatment for specific phobias in adults, there is very limited research on CBT for children with BII phobia, particularly those with serious medical conditions. At the Department of Behavioral Medicine at Karolinska University Hospital, we have developed an exposure-based CBT intervention tailored for children with BII phobia and co-occurring somatic illness. The program includes a home-based training kit with medical materials to support frequent and realistic exposure between clinic sessions. Clinical experience suggests the intervention improves fear responses and increases medical treatment adherence, but it has not yet been formally evaluated.

This study aims to evaluate the feasibility and effectiveness of this novel CBT intervention for children and adolescents with disabling BII phobia and chronic somatic conditions.

Enrollment: 30 estimated patients

Sex: All

Ages: 12 to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age 12-17 years;
2. Blood-Injection-Injury (BII) phobia;
3. Somatic disease or condition requiring regular injections and/or blood sampling;
4. Ability to read and write in Swedish.

Exclusion criteria

1. Significant cognitive or intellectual impairment;
2. Severe psychopathology (e.g., suicidality);
3. Acute trauma;
4. Ongoing or recently completed treatment for BII phobia.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

Treatment group

Experimental group

Description:

Exposure based CBT

Treatment:

Behavioral: Exposure based CBT